Teva gets approval on generic Aciphex |
|
|
|
Published
:
Thu, 22 Feb 2007 17:16
|
NEW YORK (AP) - Generic drug developer Teva Pharmaceutical Industries Ltd. said Thursday the Food and Drug Administration approved its generic version of Eisai Co.'s heartburn drug Aciphex.Israel-based Teva is involved in a patent lawsuit with Eisai over the delayed-release, 20-milligram tablets. A trial in the U.S. District Court for the Southern District of New York is scheduled for March 5.Shares of Teva fell 43 cents to $37.92 on the Nasdaq Stock Market in morning trading.Copyright 2006 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
1449.80 |
+51.73 (
3.63 %)
|
| SYMBOL (
2008-12-02 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
1347.00 |
+51.00 (
4.02 %)
|
| SYMBOL (
2008-12-02 )
|
| LAST |
CHANGE
|
|
IBM
(
4:01pm ) |
|
79.84 |
+2.94 (
3.78 %)
|
| SYMBOL (
2008-12-02 )
|
| LAST |
CHANGE
|
|
GOOGLE
(
4:00pm ) |
|
275.11 |
+9.12 (
3.37 %)
|
|
|
Print this Story
Teva suing over generic Zoloft patents 